| Description | VK-1727, a selective small molecule inhibitor of EBNA1, diminishes the DNA binding activity of EBNA1 and curtails the proliferation and metabolic activity of EBV+ cells while not affecting EBV- cells. This compound is utilized in research pertaining to multiple sclerosis [1]. |
| In vitro | VK-1727 (25 μM, 72小时) 显著减少了EBV阳性细胞中G2期的细胞数量[1]。 |
| molecular weight | 451.51 |
| Molecular formula | C29H25NO4 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |